Abstract
Derivatives of phenylethylamine and tryptamine share structural features with the non-competitive N-methyl- d-aspartate (NMDA) receptor blockers phencyclidine, ketamine, and MK-801. Tryptamine and phenylethylamine inhibited the specific binding of [ 3H]MK-801 to rat hippocampal membranes with IC 50‘s 190 and 905 μM, respectively. The corresponding amino acids phenylalanine and tryptophan were inactive, their methyl esters, however, were slightly more potent than the amines. The methyl ester of the naturally occurring l-tryptophan was 12 times more potent than the methyl ester of the d-isomer, whereas the corresponding isomers derived from phenylalanine exhibited no stereoselectivity. The potency of tryptamine was increased by substitutions as, e.g. in 5-methyltryptamine (IC 50 12 μM) and tryptophan octylester (IC 50 5.2 μM). Compounds formed in vivo from l-tryptophan and a lipophilic counterpart may function as endogenous non-competitive NMDA receptor blockers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
